These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17503896)

  • 21. Approaches to drug therapy in older cancer patients.
    Einhorn LH
    Oncology (Williston Park); 1992 Feb; 6(2 Suppl):69-73. PubMed ID: 1532740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence and oral agents with older patients.
    Maloney KW; Kagan SH
    Semin Oncol Nurs; 2011 May; 27(2):154-60. PubMed ID: 21514484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of oral cytotoxic and cytostatic drugs in cancer treatment.
    Sparreboom A; de Jonge MJ; Verweij J
    Eur J Cancer; 2002 Jan; 38(1):18-22. PubMed ID: 11750835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of antineoplastic medications in older cancer patients.
    Balducci L
    Oncology (Williston Park); 2009 Jan; 23(1):78-85. PubMed ID: 19283925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in the pharmacology of anticancer drugs in the elderly.
    Lichtman SM
    Curr Opin Oncol; 1998 Nov; 10(6):572-9. PubMed ID: 9818238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of diet on the clinical pharmacology of oral antineoplastic agents.
    Ruggiero A; Cefalo MG; Coccia P; Mastrangelo S; Maurizi P; Riccardi R
    Eur J Clin Pharmacol; 2012 Feb; 68(2):115-22. PubMed ID: 21796375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment and measurement of adherence to oral antineoplastic agents.
    Spoelstra SL; Given CW
    Semin Oncol Nurs; 2011 May; 27(2):116-32. PubMed ID: 21514481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral delivery of anticancer drugs II: the prodrug strategy.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):93-8. PubMed ID: 22960308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacoeconomic aspects of oral cytostatic agents].
    Poquet Jornet JE; Carrera-Hueso FJ; Gasent Blesa JM; Peris Godoy M
    Farm Hosp; 2011 May; 35 Suppl 2():25-31. PubMed ID: 22445506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of myelopoietic growth factors in managing cancer in the elderly.
    Balducci L; Carreca I
    Drugs; 2002; 62 Suppl 1():47-63. PubMed ID: 12479594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytotoxic chemotherapy in elderly patients: present and future].
    Freyer G; Maire P; Ardiet C; Tranchand B; Droz JP
    Bull Cancer; 1995 Jul; 82(7):531-40. PubMed ID: 7549115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of aging and cancer: how useful are pharmacokinetic tests?
    Lichtman SM
    Interdiscip Top Gerontol; 2013; 38():104-23. PubMed ID: 23503519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of cancer chemotherapy in the older person.
    Baker SD; Grochow LB
    Clin Geriatr Med; 1997 Feb; 13(1):169-83. PubMed ID: 8995106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy in the elderly.
    Lichtman SM
    Semin Oncol; 2004 Apr; 31(2):160-74. PubMed ID: 15112147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical treatment guide for dose individualisation in cancer chemotherapy.
    Canal P; Chatelut E; Guichard S
    Drugs; 1998 Dec; 56(6):1019-38. PubMed ID: 9878990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer, clinical pharmacology, and aging.
    Hutchins LF; Lipschitz DA
    Clin Geriatr Med; 1987 Aug; 3(3):483-503. PubMed ID: 3308046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polypharmacy, aging, and cancer.
    Tam-McDevitt J
    Oncology (Williston Park); 2008 Aug; 22(9):1052-5, discussion 1055, 1058, 1060. PubMed ID: 18777955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral targeted therapies: managing drug interactions, enhancing adherence and optimizing medication safety in lymphoma patients.
    Liewer S; Huddleston AN
    Expert Rev Anticancer Ther; 2015 Apr; 15(4):453-64. PubMed ID: 25683755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.